Literature DB >> 11718217

Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas.

E Gabusi1, C Lattes, M Fiorentino, A D'Errico, W F Grigioni.   

Abstract

Nasopharingeal carcinoma (NPC) is frequently associated with Epstein-Barr virus (EBV), but little is known about its pathogenesis in Western countries, where its incidence is low and EBV is not endemic. We studied 26 Italian cases of NPC: 24 of the non-keratinizing subtype, and 2 keratinizing. We used immunohistochemistry to evaluate p53, bcl-2 and Ki-67 protein expression, and in situ hybridization (ISH) to assess bcl-2 mRNA and the EBV transcript, EBER1, with bcl-2 protein and mRNA expression being compared in serial sections. As regards bcl-2, the protein or mRNA was expressed in 15/26 (58%) and 17 (65%) cases respectively, with co-expression being found only in 9 (35%) cases; 23 (88%) cases were positive for one or the other. EBER1 was detected in 17/26 (65%) cases, of which 80% and 71% coexpressed bcl-2 protein or mRNA, respectively. Only 9/26 (35%) cases had a high Ki67 proliferative index; 3/26 (12%) overexpressed p53. This study of NPC in Italy confirms the importance of EBV and bcl-2 in Western cases. The discrepancy between bcl-2 mRNA and protein expression invites investigation into a possible internal bcl-2 regulation system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718217

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  7 in total

1.  Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry.

Authors:  Xiaoyan Shi; Xianglin Yuan; Deding Tao; Jianping Gong; Guoqing Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.

Authors:  Yeşim Ertan; Mine Hekimgil; Serap Karaarslan; Saliha Soydan
Journal:  Virchows Arch       Date:  2008-02-26       Impact factor: 4.064

3.  Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.

Authors:  J S Kalpoe; P B Douwes Dekker; J H J M van Krieken; R J Baatenburg de Jong; A C M Kroes
Journal:  J Clin Pathol       Date:  2006-02-17       Impact factor: 3.411

4.  Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.

Authors:  G Bar-Sela; A Kuten; I Minkov; E Gov-Ari; O Ben-Izhak
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

5.  Absence of p53 alterations in nasopharyngeal carcinoma Spanish patients with Epstein-Barr virus infection.

Authors:  Javier S Burgos
Journal:  Virus Genes       Date:  2003-12       Impact factor: 2.332

6.  Head and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma.

Authors:  F G Casco; M J Ríos; M DE Miguel; T González; A M Moreno Fernández; H Galera-Ruiz; R González-Cámpora; R Drut; C Bacchi; H Galera-Davidson
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

7.  Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.

Authors:  Abdelwahid Saeed Ali; Mubarak Al-Shraim; Ahmed Musa Al-Hakami; Ian M Jones
Journal:  Open Virol J       Date:  2015-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.